Scolaris Content Display Scolaris Content Display

Weekly versus tri‐weekly paclitaxel with carboplatin for first‐line treatment in women with ovarian cancer

Esta versión no es la más reciente

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To compare the effectiveness and safety of weekly paclitaxel with that of three‐weekly paclitaxel, in combination with carboplatin, as first‐line chemotherapy treatment for ovarian cancer.